SYNCROSOME is proud to announce that it has joined the ETAP-Lab group
SYNCROSOME is proud to announce that it has joined the ETAP-Lab group – an offshoot of the preclinical CRO ETAP-Lab. 🚀 This acquisition marks a new stage in the company's development. Since its inception in 2000, SYNCROSOME has established itself as a key player in French preclinical...